CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Try first, evaluate later: How the FDA is approaching digital health devices

RegulatoryNeutral
AI Analysis

Summary

The FDA is selecting participants for its TEMPO pilot program on digital health devices, with Limbic joining previously announced participants Cadence and Dexcom. The article discusses the FDA's approach to evaluating digital health devices through this pilot initiative.

Importance:3/10
Sentiment:
0.00
digital healthFDA pilot programTEMPOremote monitoringbehavioral health
Related Companies

Read the original article

Published by Endpoints News on August 20, 2026 2:34 PM

Read Original